Show simple item record

dc.contributor.authorFriedrich, N
dc.contributor.authorNauck, M
dc.contributor.authorSchipf, S
dc.contributor.authorVölzke, H
dc.contributor.authorBrabant, Georg E
dc.contributor.authorWallaschofski, H
dc.date.accessioned2013-10-29T12:03:45Z
dc.date.available2013-10-29T12:03:45Z
dc.date.issued2013-09
dc.identifier.citationCross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults. 2013, 29 (6):452-62 Diabetes Metab Res Reven
dc.identifier.issn1520-7560
dc.identifier.pmid23576494
dc.identifier.doi10.1002/dmrr.2412
dc.identifier.urihttp://hdl.handle.net/10541/304721
dc.description.abstractA previous study showed an inverse association between the insulin-like growth factor I (IGF-I) and the risk of impaired glucose tolerance or diabetes mellitus. Moreover, myocardial infarction patients with high baseline IGF-I levels had a lower risk of diabetes mellitus. These data suggested a protective effect of IGF-I against the development of metabolic syndrome. However, there are no longitudinal data regarding IGF-I and metabolic syndrome. The aim of the present study was to investigate the longitudinal association between IGF-I and metabolic syndrome.
dc.language.isoenen
dc.rightsArchived with thanks to Diabetes/metabolism research and reviewsen
dc.titleCross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.en
dc.typeArticleen
dc.contributor.departmentInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße NK, D-17475, Greifswald, Germany.en
dc.identifier.journalDiabetes/Metabolism Research and Reviewsen
html.description.abstractA previous study showed an inverse association between the insulin-like growth factor I (IGF-I) and the risk of impaired glucose tolerance or diabetes mellitus. Moreover, myocardial infarction patients with high baseline IGF-I levels had a lower risk of diabetes mellitus. These data suggested a protective effect of IGF-I against the development of metabolic syndrome. However, there are no longitudinal data regarding IGF-I and metabolic syndrome. The aim of the present study was to investigate the longitudinal association between IGF-I and metabolic syndrome.


This item appears in the following Collection(s)

Show simple item record